Neutral impactResults

Sanofi India: Q3’26 Revenue Up 12% to ₹2,631 MN, Profit ₹1,027 MN

InvestyWise 1 hr ago·28 Oct 2026, 1:28 pm
Sanofi India

This update concerns Sanofi India. Read the full report at the source below.

Affected stocks

Neutral1 stock

Sanofi India

SANOFI Neutral

₹2,992.00

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Sanofi India (SANOFI).
  • Category: Results.

Why it matters

A routine update for Sanofi India. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at InvestyWise.

More Company news

More news
Company NSE

Indore Municipal Corporation — Issue of Securities

NSE · 1 hr ago

Sundram Fasteners

Sundram Fasteners Limited — Outcome of Board Meeting

Sundram Fasteners₹1,080.20▲ 0.00%

NSE · 1 hr ago

Avience Biomedicals

Avience Biomedicals Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

Avience Biomedicals₹270.70▲ 0.00%

NSE · 1 hr ago

Authum Invest & Infra

Authum Investment & Infrastructure Limited — Board Meeting Intimation

Authum Invest & Infra₹494.05▲ 0.00%

NSE · 1 hr ago

Company NSE

Grip Nva Asset 2 — Disclosure under Regulation 7(1)

NSE · 1 hr ago

Mukesh Ambani’s telecom journey: from losing Reliance Infocomm to listing Jio Platforms

JIO Platforms₹1,417.50▲ 0.00%

Mint · 1 hr ago

R R Kabel

R R Kabel Limited — Outcome of Board Meeting

R R Kabel₹2,207.40▲ 0.00%

NSE · 1 hr ago

Iifl Capital Services

IIFL Capital Services Limited — Change in Directors/KMP/SMP/Auditor/RTA

Iifl Capital Services₹346.20▲ 0.00%

NSE · 1 hr ago

Company NSE

Grip Nva Asset 2 — Disclosure under Regulation 6(1)

NSE · 1 hr ago

Latest headlines

More news

Sugar will likely be a bitter pill for Indian consumers over the next year

BusinessLine · 1 hr ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.